[Skip to Content]
[Skip to Content Landing]
Citations 0
The World in Medicine
November 11, 1998

Improving Stroke Outcomes

Author Affiliations

Not Available

Not Available

JAMA. 1998;280(18):1559. doi:10.1001/jama.280.18.1559-JWM80008-3-1

Thrombolytic therapy with the drug alteplase can help some patients lead more independent lives following a stroke, even when the drug is given more than 3 hours after symptoms begin.

Researchers reported in the October 17 Lancet on 800 patients who were randomly assigned to receive alteplase or placebo. Most were treated from 3 to 6 hours after symptoms appeared. Alteplase is a recombinant tissue-type plasminogen activator that previous studies found to be effective in limiting brain injury from stroke if it is given within 3 hours of the onset of symptoms. The problem is that most patients don't seek treatment in time to benefit from the drug.

First Page Preview View Large
First page PDF preview
First page PDF preview